We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon Seeks Expanded Indication for Pain Treatment Fentora
Cephalon Seeks Expanded Indication for Pain Treatment Fentora
November 16, 2007
Cephalon has filed a supplemental new drug application (sNDA) for its pain drug Fentora for the management of breakthrough pain in opioid-tolerant patients with chronic pain, a much broader indication than what the product is approved for.